Peter Oelschlaeger - Search Results

Year	Number of Results
2002	1
2003	2
2005	3
2006	3
2007	2
2008	1
2010	3
2011	1
2012	2
2013	3
2014	2
2015	6
2016	3
2017	3
2018	3
2019	1
2021	3
2022	2
2023	3
2024	1

1

β-Lactamases: Sequence, Structure, Function, and Inhibition.

Oelschlaeger P. Oelschlaeger P. Biomolecules. 2021 Jul 5;11(7):986. doi: 10.3390/biom11070986. Biomolecules. 2021. PMID: 34356610 Free PMC article.

2

Structure and Mechanism-Guided Design of Dual Serine/Metallo-Carbapenemase Inhibitors.

Chen C, Oelschlaeger P, Wang D, Xu H, Wang Q, Wang C, Zhao A, Yang KW. Chen C, et al. Among authors: oelschlaeger p. J Med Chem. 2022 Apr 28;65(8):5954-5974. doi: 10.1021/acs.jmedchem.2c00213. Epub 2022 Apr 14. J Med Chem. 2022. PMID: 35420040 Review.

3

Monoclonal Antibody Therapy against Acinetobacter baumannii.

Nielsen TB, Yan J, Slarve M, Lu P, Li R, Ruiz J, Lee B, Burk E, Talyansky Y, Oelschlaeger P, Hurth K, Win W, Luna BM, Bonomo RA, Spellberg B. Nielsen TB, et al. Among authors: oelschlaeger p. Infect Immun. 2021 Sep 16;89(10):e0016221. doi: 10.1128/IAI.00162-21. Epub 2021 Jul 26. Infect Immun. 2021. PMID: 34310884 Free PMC article.

4

Strategies to Name Metallo-β-Lactamases and Number Their Amino Acid Residues.

Oelschlaeger P, Kaadan H, Dhungana R. Oelschlaeger P, et al. Antibiotics (Basel). 2023 Dec 16;12(12):1746. doi: 10.3390/antibiotics12121746. Antibiotics (Basel). 2023. PMID: 38136780 Free PMC article. Review.

5

Molecular Mechanisms and the Significance of Synonymous Mutations.

Oelschlaeger P. Oelschlaeger P. Biomolecules. 2024 Jan 20;14(1):132. doi: 10.3390/biom14010132. Biomolecules. 2024. PMID: 38275761 Free PMC article. Review.

6

A self-reported inhibitor of metallo-carbapenemases for reversing carbapenem resistance.

Chen C, Li J, Dan H, He J, Wang D, Oelschlaeger P, Wang N, Zhang Y, Pei Y, Yang KW. Chen C, et al. Among authors: oelschlaeger p. Int J Biol Macromol. 2023 Dec 1;252:126441. doi: 10.1016/j.ijbiomac.2023.126441. Epub 2023 Aug 20. Int J Biol Macromol. 2023. PMID: 37607651

7

A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases.

Chen C, Xu Y, Oelschlaeger P, Brem J, Liu L, Wang D, Sun H, Yang KW. Chen C, et al. Among authors: oelschlaeger p. Chem Commun (Camb). 2023 Jul 25;59(60):9227-9230. doi: 10.1039/d3cc02373g. Chem Commun (Camb). 2023. PMID: 37417329

8

Virtual Screening and Experimental Testing of B1 Metallo-β-lactamase Inhibitors.

Kang JS, Zhang AL, Faheem M, Zhang CJ, Ai N, Buynak JD, Welsh WJ, Oelschlaeger P. Kang JS, et al. Among authors: oelschlaeger p. J Chem Inf Model. 2018 Sep 24;58(9):1902-1914. doi: 10.1021/acs.jcim.8b00133. Epub 2018 Aug 29. J Chem Inf Model. 2018. PMID: 30107123 Free PMC article.

9

Polymorphisms in common antihypertensive targets: Pharmacogenomic implications for the treatment of cardiovascular disease.

Brown D, Alcala H, Oelschlaeger P, Andresen BT. Brown D, et al. Among authors: oelschlaeger p. Adv Pharmacol. 2022;94:141-182. doi: 10.1016/bs.apha.2022.04.001. Epub 2022 May 24. Adv Pharmacol. 2022. PMID: 35659371

10

Role of Synonymous Mutations in the Evolution of TEM β-Lactamase Genes.

Faheem M, Zhang CJ, Morris MN, Pleiss J, Oelschlaeger P. Faheem M, et al. Among authors: oelschlaeger p. Antimicrob Agents Chemother. 2021 May 18;65(6):e00018-21. doi: 10.1128/AAC.00018-21. Print 2021 May 18. Antimicrob Agents Chemother. 2021. PMID: 33820762 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

46 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year